Regulus Therapeutics (RGLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,634 | -46,358 | -33,567 | -19,505 | -8,469 |
| Depreciation Amortization | -115 | -1,210 | -912 | -409 | 211 |
| Accounts payable and accrued liabilities | -747 | 743 | 588 | 396 | 202 |
| Other Working Capital | -3,113 | -1,882 | -663 | -3,357 | -1,501 |
| Other Operating Activity | 2,996 | 7,034 | 4,726 | 2,496 | 815 |
| Operating Cash Flow | $-10,613 | $-41,673 | $-29,828 | $-20,379 | $-8,742 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 21,500 | -35,643 | -59,643 | -78,315 | -78,315 |
| PPE Investments | N/A | -340 | -340 | -312 | -229 |
| Investing Cash Flow | $21,500 | $-35,983 | $-59,983 | $-78,627 | $-78,544 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | 0 | -1,377 | -1,377 | -1,377 | -826 |
| Common Stock Issued | 45 | 93,794 | 93,794 | 93,738 | 93,931 |
| Financing Cash Flow | $45 | $92,417 | $92,417 | $92,361 | $93,105 |
| Beginning Cash Position | 38,590 | 23,829 | 23,829 | 23,829 | 23,829 |
| End Cash Position | 49,522 | 38,590 | 26,435 | 17,184 | 29,648 |
| Net Cash Flow | $10,932 | $14,761 | $2,606 | $-6,645 | $5,819 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,613 | -41,673 | -29,828 | -20,379 | -8,742 |
| Capital Expenditure | 0 | -340 | -340 | -312 | -229 |
| Free Cash Flow | -10,613 | -42,013 | -30,168 | -20,691 | -8,971 |